Literature DB >> 21411081

Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.

Dietmar Spitzer1, Johannes Wogatzky, Maximilian Murtinger, Mathias H Zech, Robert Haidbauer, Nicolas H Zech.   

Abstract

The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21411081     DOI： 10.1016/j.fertnstert.2011.02.032

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma Mourad; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-30

2.  Minimum dose of hCG to trigger final oocyte maturation and prevent OHSS in a long GnRHa protocol.

Authors:  Xin Chen; Shi-Ling Chen; Yu-Xia He; De-Sheng Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

3.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma M Mourad; Aihua Wang; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2021-04-14

4.  Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.

Authors:  Laura D Ratner; Betina Gonzalez; Petteri Ahtiainen; Noelia P Di Giorgio; Matti Poutanen; Ricardo S Calandra; Ilpo T Huhtaniemi; Susana B Rulli
Journal:  Endocrinology       Date:  2012-11-01       Impact factor: 4.736
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.